WHO ICTRP trial
Clinical Efficacy and Mechanism Study of Compound Danshen Dripping Pills in…
ChiCTR2500107551 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500107551 |
|---|---|
| Public title | Clinical Efficacy and Mechanism Study of Compound Danshen Dripping Pills in Improving Diabetic Renal Fibrosis |
| Scientific title | Clinical Efficacy and Mechanism Study of Compound Danshen Dripping Pills in Improving Diabetic Renal Fibrosis |
| Primary sponsor | General Hospital of Central Theater Command of the Chinese People's Liberation Army |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Diabetic nephropathy |
| Interventions | Intervention group:ake 10 pills of Compound Danshen Dripping Pills each time, 3 times a day.;Control group:Conventional treatment |
| Registration date | Aug 13, 2025 |
| Target size | Intervention group:79;Control group:79 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: